CURIS INC (CRIS)
Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE
What they're doing
Not enough recent activity to summarise.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing acquisition or disposition of assets
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | KAITIN KENNETH I | director | P | 10,000 | 0.55 | $5,500 |
| 2026-03-20 | Zung Jonathan B. | officer | C | 66,667 | — | — |
| 2026-03-20 | Hamdy Ahmed MD | officer | C | 66,667 | — | — |
| 2026-03-20 | Duvall Diantha | officer | C | 66,666 | — | — |
| 2026-03-20 | Dentzer James E | director | C | 133,333 | — | — |
| 2026-03-20 | Rubin Marc | director | C | 26,667 | — | — |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.